X-treme Freeze Gel
Product Images NDC 67777-144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for X-treme Freeze (NDC 67777-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dynarex Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1441 Primary Display Panel (1441 Primary Display Panel)

1441 Primary Display Panel (1441 Primary Display Panel)
This is a description of a pain-relieving cold therapy gel named "EME FREEZE" distributed by Dynarex Corporation located in Rangeburg, NY. The product claims to provide temporary relief from minor aches and pains associated with sore muscles due to arthritis, backaches, strains, and sprains as it contains Menthol USP 4% active. However, it is recommended to ask a doctor before using if an individual has sensitive skin. It must be kept away from excessive heat or open flame as it is flammable. The rest of the information is not available due to errors.*
FDA Label Image

1442 Primary Display Panel (1442 Primary Display Panel)

1442 Primary Display Panel (1442 Primary Display Panel)
The text is a product label of Dynarex Corporation's Pain Relieving Cold Therapy Gel for temporary relief from minor aches and pains of sore muscles and joints associated with arthritis, backache, strains, and sprains. It contains menthol USP 54 active ingredient and comes in a 41l. 0z. (118 mL) tube. The product is for external use only, and should not be applied to wounds or on damaged skin. Customers are warned not to use it with other ointments, creams, sprays, or medications and should avoid contact with eyes or mucous membranes. The product must not be used with a heating pad or device, and customers are advised to stop using it if the condition worsens. The label includes other necessary information about the product.*
FDA Label Image

1444 Primary Display Panel (1444 Primary Display Panel)

1444 Primary Display Panel (1444 Primary Display Panel)
This is a label of a pain-relieving solution manufactured by Dynarex Corporation in India. It contains active and inactive ingredients, directions, and warnings. The solution is only for external use and may help relieve minor aches and pains associated with muscle and joint soreness due to sprains, strains, and arthritis. It should not be applied to damaged skin or wounds. Users should not bandage the affected areas or use it with heating pads or devices. If the condition worsens or persists for more than seven days, users should contact a doctor. It is flammable and should be kept away from excessive heat, and children should be prevented from accessing it. If accidentally swallowed, users should contact a physician or Poison Control Center immediately. Inactive ingredients include water, extracts, and chemicals. Contact information for Dynarex Corporation is provided for any necessary inquiries.*
FDA Label Image

1447 Primary Display Panel (1447 Primary Display Panel)

1447 Primary Display Panel (1447 Primary Display Panel)
This product is a gallon of pain-relieving cold therapy gel with the active ingredients of 5% Menthol USP and Actre (not clear what this is). Produced for Dynarex Corporation with a warning not to use except for external use and to keep out of the reach of children. The product has other specific instructions on how to use it. It contains some inactive ingredients as well, and the reorder number is 1447.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.